ZXFC(SZ:002915) EBSCN·2026-02-02 12:11Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for future performance [4][6]. Core Insights - The company is expected to achieve a net profit attributable to shareholders of between 16 million to 20 million yuan in 2025, marking a turnaround from previous losses [1]. - The recovery in demand for pesticide intermediates has significantly improved the company's performance, particularly through the operational improvements at its subsidiary, Fujian Gaobao, which has reduced its losses substantially [2]. - The company plans to raise 186 million yuan through a private placement to expand its production capacity in the new materials sector, specifically for BPEF and BPF products, which are widely used in various high-tech applications [3]. Summary by Sections Financial Forecasts - The company’s projected net profits for 2025, 2026, and 2027 are 18 million, 75 million, and 110 million yuan respectively, with a notable increase in revenue expected [4][5]. - Revenue is forecasted to grow from 1,576 million yuan in 2025 to 2,129 million yuan by 2027, reflecting a compound annual growth rate [5][9]. Profitability and Valuation Metrics - The gross margin is expected to improve from 15.5% in 2025 to 19.1% in 2027, indicating enhanced operational efficiency [11]. - The company’s price-to-earnings ratio (P/E) is projected to decrease from 410 in 2025 to 67 by 2027, suggesting a more favorable valuation as profitability improves [12]. Operational Developments - The company is enhancing its production capabilities to meet the growing demand in the new materials sector, which is expected to drive future growth [3]. - The operational efficiency improvements and strategic adjustments in product structure and sales strategies are anticipated to contribute to double-digit revenue growth in 2025 [2].